
浏览全部资源
扫码关注微信
纸质出版日期:2013
移动端阅览
刘洪敏, 王春霞. 加味抑肝散治疗小儿厌食症[J]. 中国实验方剂学杂志, 2013,19(7):315-317.
LIU Hong-min, WANG Chun-xia. Clinical Observation on Jiawei Yigan San for Treatment of Infantile Fastidium[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(7): 315-317.
刘洪敏, 王春霞. 加味抑肝散治疗小儿厌食症[J]. 中国实验方剂学杂志, 2013,19(7):315-317. DOI: 10.11653/zgsyfjxzz2013070315.
LIU Hong-min, WANG Chun-xia. Clinical Observation on Jiawei Yigan San for Treatment of Infantile Fastidium[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(7): 315-317. DOI: 10.11653/zgsyfjxzz2013070315.
目的: 探讨加味抑肝散治疗小儿厌食症(肝脾不调证)的临床疗效。 方法: 83例小儿厌食症患儿随机分为观察组42例和对照组41例。对照组采用小儿健脾化积口服液
2~3岁5~10 mL/次
>3岁10 mL/次
3次/d
口服;观察组采用加味抑肝散
1剂/d
常规水煎分多次服用。疗程均为4周。检测治疗前后血清微量元素Zn和血清神经肽Y(NPY)。 结果: 观察组血清Zn水平略高于对照组;两组血清NPY水平均较治疗前上升
观察组上升更显著(P<0.01);治疗后两组BMI均较治疗前上升(P<0.01)
观察组高于对照组(P<0.05);观察组总有效率97.62%
高于对照组的82.93%(P<0.05);治疗后观察组肝脾不调证证候积分(2.5±2.4)分
低于对照组的(7.6±3.2)分
(P<0.01);观察组证候总有效率97.62%
优于对照组的80.49%(P<0.05) 结论: 加味抑肝散能使患儿饮食量增加
BMI指数升高
能明显升高患儿血清NPY水平
对小儿厌食症(肝脾不调)有较好的疗效。
Objective: To explore the clinical curative effect on Jiawei Yigan san (JYS) for treatment of infantile fastidium. Method: Eighty-three cases of children with infantile fastidium were randomly divided into the observation group (n=42) and the control group (n=41). The control group was given the pediatric Jianpi Huaji oral liquid (2-3 years old 5-10 mL
tid;>3 years old 10 mL
tid). The observation group was received JYS
1 dose of tap water decoction (divided in a few portions to take) daily. The treatment lasted for 4 weeks. Serum trace elements Zn and serum neuropeptide Y (NPY) were investigated before and after the treatment. Result: Serum Zn level in the observation group was slightly higher than that in the control group. Serum NPY level in two groups was increased; compared with that before treatment
it was more significant in the observation group (P<0.01). After treatment
the total effective rate in the observation group was 97.62%
higher than that of 82.93% in the control group (P<0.05). After treatment
the score for liver and spleen syndrome in the observation group was (2.5±2.4) which was lower than (7.6±3.2) in the control group (P<0.01). In two groups
body mass index (BMI) after therapy was increased compared with that before treatment (P<0.01)
the increase in observation group was higher than that in the control group (P<0.05).After treatment
the total effective rate in the observation group syndrome was 97.62%
which was higher than 80.49% in the control group (P<0.05). Conclusion: Treatment of JYS can increase BMI
food intake and serum NPY level. It has good therapeutic effect for infantile fastidium.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621